Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling - Wikidata - wikimedia - TriplyDB

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling

http://www.wikidata.org/entity/Q35742375

about

Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.Down-regulation of Krüppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-β1.N-acetylgalactosaminyltransferases in cancer.Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells.LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers

P2860

Q36998213-B162902C-2E99-4E81-B75C-3E545D2B4321 Q37174016-F43165D0-9A6A-41E6-BDC2-582867A19121 Q37520619-5827468D-F9AF-45EF-B7F9-F14F5FD94C3B Q37619873-E9F99DC4-D1F6-4376-98A8-FBB4AB71BFD8 Q37688082-08B03217-460D-47A6-9116-1D3A77D15E1F Q38722581-F492DC10-FC9B-4116-A2B9-E7159B1E8ED3 Q42335706-2FEDD8A3-89B4-4580-9A6F-9B8875B7AA18 Q54985550-831CD1F3-7B15-4B8B-B789-623638EC90CA Q55348071-3AAF7D29-3330-4753-9E9B-4DEA31716BA0 Q56889497-127543D9-EC95-44EC-B3FA-839A98987D7D Q58774191-F18A9AAB-16D4-4328-B7EF-BA1762C63F20

P2860

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling

http://www.wikidata.org/entity/Q35742375

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@ast

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@en

type

label

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@ast

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@en

prefLabel

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@ast

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@en

P1433

Q35742375-5DEA24D5-9547-4E31-8079-C0286EC80E39

P1476

Q35742375-074E3BBF-BFCC-4198-845C-0862FF97CBF7

P2093

Q35742375-02C8A067-DF33-4F15-9A31-797F9BF060F5

Q35742375-689FD1D3-8AC5-47AE-998E-FD566B1532B1

Q35742375-692373CE-9414-4DBE-B452-5D8213CCC1DC

Q35742375-76C76A59-AC78-4B0D-97DD-F43901C4207D

Q35742375-83B1E608-D9A8-4013-B68C-78C65092F6DD

Q35742375-B3CD0181-6D92-41BD-BA86-0819CFDA7CA3

Q35742375-C16026D7-7648-429B-953F-751473D97571

Q35742375-F18142DC-CA7B-4E3B-B72F-F96A52A8EDBF

P2860

Q35742375-01709131-E652-4AB1-95B8-91A17B1A1B80

Q35742375-1211DE18-A149-44B4-A86F-DD90E88EA319

Q35742375-1619DC72-FEF0-430A-97FE-9238DC99935D

Q35742375-2C1510E8-EEB3-4D73-970A-30628D5FA0A7

Q35742375-2EC8D486-9635-44C8-A437-B851B89FFD41

Q35742375-34B3E69D-FF0F-4C33-B9AC-27CEDDDF3FA8

Q35742375-3A9E87FE-E843-4895-8640-7602B734A39B

Q35742375-3B84798F-2BC9-4189-A436-3318DFB1D99F

Q35742375-4407AF70-002C-41C8-AFDE-A9A01695217E

Q35742375-4B1D1C2C-7CD2-4098-9C92-7592F773A02C

P304

Q35742375-EEF934E8-3BD6-4D07-9B62-DBEE8B9A8045

P31

Q35742375-C52A504E-1026-4B1A-B391-1E52861C89D2

P356

Q35742375-5DF5B314-5FC0-4B2A-8740-34C475A7786D

P407

Q35742375-44CF7CF7-7567-41DC-829E-3874C0A4ABAE

P433

Q35742375-8AF4295B-2902-4C83-8A32-EDFC21AB9C8B

P478

Q35742375-8DDAB29A-94C8-4C2F-93BB-E5B8E6FFABC8

P50

Q35742375-583D6B21-DD74-46B8-BC13-6D033E264C17

Q35742375-5E886528-7E00-4EDE-BFAF-4C1119F78E1C

Q35742375-752D4EA9-FCB9-4FCB-9B0D-FD0CA4B9CFCF

Q35742375-C6E0D43C-81A2-4135-9095-044AAEB23048

P577

Q35742375-790A4EDF-D000-46F0-A21E-0696A280D92F

P5875

Q35742375-9514A9A1-FFA9-4C0E-A2DB-CD87FF555FDF

P698

Q35742375-F0E6707B-2B7C-485E-A3B7-1C2BFC4F371A

P932

Q35742375-A4077CD2-BA7A-4D9E-880F-D6098B40F25C

P356

ONCOTARGET.3117

P1433

P1476

Knockdown of GALNT1 suppresses ...... by suppressing EGFR signaling

@en

P2093

Chia-Lang Hsu

http://www.w3.org/2001/XMLSchema#string

Chih-Hsing Chou

http://www.w3.org/2001/XMLSchema#string

I-Rue Lai

http://www.w3.org/2001/XMLSchema#string

Ji-Shiang Hung

http://www.w3.org/2001/XMLSchema#string

John Huang

http://www.w3.org/2001/XMLSchema#string

Miao-Juei Huang

http://www.w3.org/2001/XMLSchema#string

Min-Chuan Huang

http://www.w3.org/2001/XMLSchema#string

Ya-Wen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family

Integration of biological networks and gene expression data using Cytoscape

Functional characterization and expression analysis of members of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family from Drosophila melanogaster.

Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates.

Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer.

The quest to overcome resistance to EGFR-targeted therapies in cancer.

Enrichment map: a network-based method for gene-set enrichment visualization and interpretation.

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.

Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.

P304

5650-5665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3117

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273064567

http://www.w3.org/2001/XMLSchema#string

P698

25730904

http://www.w3.org/2001/XMLSchema#string

P932

4467392

http://www.w3.org/2001/XMLSchema#string